个人简历

教育背景
2002年9月—2006年7月：陕西中医学院，中药学，医学学士
2006年9月—2009年7月：沈阳药科大学，生药学，理学硕士
2009年9月—2012年7月：韩国东亚大学，微生物生命工学，理学博士
工作经历
2012年8月—今：天津医科大学，药学院，讲师
荣誉奖励
2015年天津市“131”创新型人才培养工程第三层次人才

研究领域

抗肿瘤分子靶向药物研究

近期论文

(1) Yuling Qiu, Yali Chen, Haiyang Yu, Qianxiang Zhou, Ran Wang, Meihua Jin, Dexin Kong*. Molecular cloning of the Bombus terrestris bumblebee venom protein phospholipase A2 and its anti-leukemia effects on K562 cells, Journal of Asia-Pacific Entomology, 2017, 20(2): 699-704
(2) Wennan Zhao#, Yuling Qiu#, Dexin Kong*, Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy, Acta Pharm Sin, 2017, 7(1): 27-37（并列第一作者）
(3) Yali Chen, Qianxiang Zhou, Lei Zhang, Yuxu Zhong, Guanwei Fan, Zhe Zhang, Ran Wang, Meihua Jin, Yuling Qiu*, Dexin Kong*. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5, Oncotarget, 2017, 8(17): 28906-28921.（并列通讯作者）
(4) Qianxiang Zhou, Yali Chen, Lei Zhang, Yuxu Zhong, Zhe Zhang, Ran Wang, Meihua Jin, Min Gong, Yuling Qiu*, Dexin Kong*. Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells, Oncotarget, 2017, 8(24): 39064-39076.（并列通讯作者）
(5) Yali Chen, Qianxiang Zhou, Lei Zhang, Ran Wang, Meihua Jin,Yuling Qiu*, Dexin Kong*, Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells, Oncology Reports, 2016, 36(6): 3643-3650（并列通讯作者）
(6) Qianxiang Zhou, Yali Chen, Xi Chen, Wennan Zhao, Yuqing Zhong, Ran Wang, Meihua Jin, Yuling Qiu*, Dexin Kong*, In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells, International Journal of Biological Sciences, 2016, 12(6): 631-638.（并列通讯作者）
(7) Yuling Qiu, Kwang Sik Lee, Young Moo Choo, Dexin Kong, Hyung Joo Yoon, Byung Rae Jin*, Molecular cloning and antifibrinolytic activity of a serine protease inhibitor of bumblebee (Bombus terrestris) venom, Toxicon, 2013, 63: 1-6.